AKT1 and Hepatic steatosis: In human liver tumors, increased expression of YAP is associated with high levels of p-AKT [29], and recent study has showed that Hippo pathway prevented hepatic steatosis and liver tumors by suppressing the insulin receptor substrate (IRS)/AKT signaling [43].